665 related articles for article (PubMed ID: 16953178)
21. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
[TBL] [Abstract][Full Text] [Related]
22. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
23. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.
Park YK; Choi JY; Jung SI; Park KH; Lee H; Jung DS; Heo ST; Kim SW; Chang HH; Cheong HS; Chung DR; Peck KR; Song JH; Ko KS
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):389-95. PubMed ID: 19631092
[TBL] [Abstract][Full Text] [Related]
24. Evolution of multidrug-resistant Acinetobacter baumannii isolates obtained from elderly patients with respiratory tract infections.
Canduela MJ; Gallego L; Sevillano E; Valderrey C; Calvo F; Pérez J
J Antimicrob Chemother; 2006 Jun; 57(6):1220-2. PubMed ID: 16597632
[TBL] [Abstract][Full Text] [Related]
25. Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.
Poirel L; Lebessi E; Héritier C; Patsoura A; Foustoukou M; Nordmann P
Clin Microbiol Infect; 2006 Nov; 12(11):1138-41. PubMed ID: 17002616
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
[TBL] [Abstract][Full Text] [Related]
27. Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula.
Da Silva GJ; Quinteira S; Bértolo E; Sousa JC; Gallego L; Duarte A; Peixe L;
J Antimicrob Chemother; 2004 Jul; 54(1):255-8. PubMed ID: 15190040
[TBL] [Abstract][Full Text] [Related]
28. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
Mendes RE; Bell JM; Turnidge JD; Castanheira M; Jones RN
J Antimicrob Chemother; 2009 Jan; 63(1):55-9. PubMed ID: 18957398
[TBL] [Abstract][Full Text] [Related]
29. Rapid control of a hospital-wide outbreak caused by extensively drug-resistant OXA-72-producing Acinetobacter baumannii.
Lin WR; Lu PL; Siu LK; Chen TC; Lin CY; Hung CT; Chen YH
Kaohsiung J Med Sci; 2011 Jun; 27(6):207-14. PubMed ID: 21601165
[TBL] [Abstract][Full Text] [Related]
30. First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals.
Bakour S; Touati A; Bachiri T; Sahli F; Tiouit D; Naim M; Azouaou M; Rolain JM
J Infect Chemother; 2014 Nov; 20(11):696-701. PubMed ID: 25240726
[TBL] [Abstract][Full Text] [Related]
31. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.
Lolans K; Rice TW; Munoz-Price LS; Quinn JP
Antimicrob Agents Chemother; 2006 Sep; 50(9):2941-5. PubMed ID: 16940085
[TBL] [Abstract][Full Text] [Related]
32. Molecular epidemiology of carbapenem-resistant Acinetobacter spp. from XiangYa Hospital, in Hunan Province, China.
Chen Z; Liu W; Zhang Y; Li Y; Jian Z; Deng H; Zou M; Liu Y
J Basic Microbiol; 2013 Feb; 53(2):121-7. PubMed ID: 22581767
[TBL] [Abstract][Full Text] [Related]
33. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital.
Huang L; Sun L; Xu G; Xia T
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):326-32. PubMed ID: 18687557
[TBL] [Abstract][Full Text] [Related]
34. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
[TBL] [Abstract][Full Text] [Related]
35. Investigation of metallo-beta-lactamase producing strains of Pseudomonas aeruginosa and Acinetobacter baumannii by E-test, disk synergy and PCR.
Aktaş Z; Kayacan CB
Scand J Infect Dis; 2008; 40(4):320-5. PubMed ID: 17934980
[TBL] [Abstract][Full Text] [Related]
36. Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
Yang HY; Lee HJ; Suh JT; Lee KM
Yonsei Med J; 2009 Dec; 50(6):764-70. PubMed ID: 20046415
[TBL] [Abstract][Full Text] [Related]
37. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
[TBL] [Abstract][Full Text] [Related]
38. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Wang H; Guo P; Sun H; Wang H; Yang Q; Chen M; Xu Y; Zhu Y
Antimicrob Agents Chemother; 2007 Nov; 51(11):4022-8. PubMed ID: 17846127
[TBL] [Abstract][Full Text] [Related]
39. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
40. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
